Lophius Biosciences Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
M&A
Lophius Biosciences General Information
Description
Developer of immune diagnostic systems designed to transform treatment paradigms and patient management with molecular diagnostics. The company's systems facilitate an efficient stimulation of a broad spectrum of clinically relevant immune effector cells to accurately measure cell-mediated immunity, enabling physicians to differentiate between active T-cells versus T-memory cells and identify patients with a contagious active disease and latent infection.
Contact Information
Website
www.lophius.comCorporate Office
- Am BioPark 13
- 93053 Regensburg
- Germany
Corporate Office
- Am BioPark 13
- 93053 Regensburg
- Germany
Lophius Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 08-Mar-2021 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 19-Sep-2019 | Completed | Generating Revenue | |||
| 10. Grant | 31-May-2017 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 16-Mar-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 01-Jul-2016 | Completed | Generating Revenue | |||
| 7. Grant | 28-Oct-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 10-Sep-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 08-May-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 22-Jan-2013 | $5.22M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 18-Jul-2011 | $2.29M | $5.22M | Completed | Generating Revenue |
Lophius Biosciences Comparisons
Industry
Financing
Details
Lophius Biosciences Competitors (6)
One of Lophius Biosciences’s 6 competitors is numares, a Venture Capital-Backed company based in Regensburg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| numares | Venture Capital-Backed | Regensburg, Germany | ||||
| Glycotope | Formerly VC-backed | Berlin, Germany | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Apogenix | Venture Capital-Backed | Heidelberg, Germany | ||||
| Complix | Venture Capital-Backed | Diepenbeek, Belgium |
Lophius Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lophius Biosciences Patents
Lophius Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180267024-A1 | Composition for determination of cell-mediated immune responsiveness | Inactive | 08-Jun-2015 | ||
| US-20220373538-A1 | Composition for determination of cell-mediated immune responsiveness | Inactive | 08-Jun-2015 | ||
| CA-2893068-A1 | Method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive t cells | Inactive | 30-Nov-2012 | ||
| EP-2926135-A1 | Method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive t cells | Inactive | 30-Nov-2012 | ||
| US-20150309015-A1 | Method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive t cells | Inactive | 30-Nov-2012 | G01N33/5091 |
Lophius Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lophius Biosciences Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bayern Kapital | Venture Capital | Minority | ||
| Bundesministerium für Bildung und Forschung | Government | |||
| Heidelberg Innovation Fonds Management | Venture Capital | Minority | ||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| Horizon 2020 | Government |
Lophius Biosciences FAQs
-
When was Lophius Biosciences founded?
Lophius Biosciences was founded in 2002.
-
Where is Lophius Biosciences headquartered?
Lophius Biosciences is headquartered in Regensburg, Germany.
-
What is the size of Lophius Biosciences?
Lophius Biosciences has 14 total employees.
-
What industry is Lophius Biosciences in?
Lophius Biosciences’s primary industry is Diagnostic Equipment.
-
Is Lophius Biosciences a private or public company?
Lophius Biosciences is a Private company.
-
What is Lophius Biosciences’s current revenue?
The current revenue for Lophius Biosciences is .
-
How much funding has Lophius Biosciences raised over time?
Lophius Biosciences has raised $24M.
-
Who are Lophius Biosciences’s investors?
Bayern Kapital, Bundesministerium für Bildung und Forschung, Heidelberg Innovation Fonds Management, High-Tech Gründerfonds, and Horizon 2020 are 5 of 10 investors who have invested in Lophius Biosciences.
-
Who are Lophius Biosciences’s competitors?
numares, Glycotope, Adaptimmune Therapeutics, Apogenix, and Complix are some of the 6 competitors of Lophius Biosciences.
-
When was Lophius Biosciences acquired?
Lophius Biosciences was acquired on 08-Mar-2021.
-
Who acquired Lophius Biosciences?
Lophius Biosciences was acquired by Mikrogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
